ELTX
Elicio Therapeutics Inc.
1.80$
-2.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 64.3% | 60.2% | 57.7% | 42.5% | 79.8% | 73.4% | 74.4% | 76.5% | 75.9% | 74.7% | 71.4% | 81.3% | |
| 47.9% | 47.5% | 48.4% | 24.3% | 67.8% | 62.5% | 65.2% | 74.8% | 72.9% | 71.8% | 65.9% | 74.9% | |
| 47.9% | 47.5% | 48.4% | 24.3% | 67.8% | 62.5% | 65.2% | 74.8% | 72.9% | 71.8% | 65.9% | 74.9% | |
| 0.3% | – | – | 0.6% | 0.0% | – | – | – | – | – | – | – | |
| -0.3% | – | – | – | – | – | – | – | – | – | – | – | |
| 57.1% | 58.1% | 80.1% | 110.5% | 149.5% | 140.1% | 68.4% | 93.8% | 86.5% | 93.7% | 106.3% | 74.7% | |
| 37.1% | 35.9% | 24.3% | 48.2% | 23.5% | 40.9% | 40.6% | 33.6% | 23.0% | 31.4% | 31.9% | 29.4% | |
| 3.0% | 3.4% | 3.6% | 5.4% | 2.3% | 3.2% | 3.3% | 3.2% | 3.5% | 3.9% | 4.6% | 3.4% | |
| 14.2% | 16.1% | 4.5% | 6.7% | 5.2% | 3.7% | 14.3% | 13.1% | 1.1% | 2.6% | 1.2% | 2.7% | |
| – | – | – | – | 51.7% | 71.1% | – | 31.6% | 34.4% | 36.4% | 41.8% | 30.4% | |
| 42.9% | 41.9% | 19.9% | -10.5% | -49.5% | -40.1% | 31.6% | 6.2% | 13.5% | 6.3% | -6.3% | 25.3% | |
| -430.0% | -523.8% | -629.2% | -1,023.9% | -469.1% | -688.8% | -729.5% | -731.1% | -798.9% | -903.5% | -1,082.0% | -809.8% | |
| 13.2% | 35.4% | 42.0% | 71.6% | 35.4% | 43.3% | 46.0% | 54.4% | 59.0% | 59.2% | 80.3% | 61.4% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.